Ingrezza — Number Of Separate Commercial Production Sites

Analysis

StatementSegment

CategoryRisk

SignalContext dependent

VolatilityStable

First reportedQ1 2018

Last reportedQ4 2019Feb 7, 2020

How to read this metric

An increase suggests expanded capacity or risk mitigation through geographic diversification, while a decrease may indicate consolidation or potential supply chain vulnerability.

Detailed definition

This metric tracks the total count of distinct manufacturing facilities authorized to produce the commercial supply of a...

Peer comparison

Peer pharmaceutical companies typically report manufacturing footprint metrics to demonstrate supply chain robustness and regulatory compliance readiness.

Metric ID: nbix_segment_ingrezza_number_of_separate_commercial_production_sites

Similar Metrics at Other Companies

International Flavors & FragrancesIFF View metric

DowDOW View metric

GE VernovaGEV View metric

RBC BearingsRBC View metric

TTM TechnologiesTTMI View metric

DowDOW View metric

Frequently Asked Questions

What does ingrezza — number of separate commercial production sites mean?: The total number of unique manufacturing locations currently producing a specific commercial drug.